A monthly supply of generic versions of Novo Nordisks (NVO) GLP-1 therapy, semaglutide, marketed as Ozempic and Wegovy, could cost less than $3 per person, according to a new study posted this week
K., Tong, J., DAlessio, D
Patients should ask their provider which ingredient form is being used
These prescription therapies offer well-documented clinical results, established dosing schedules, and proven safety profiles
Because PT-141 doesnt rely on the vascular system to produce an erection, its considered a suitable option for men who cant take traditional erectile dysfunction medications due to underlying health conditions, such as heart disease or high blood pressure
Previous unsuccessful weight loss attempts and the absence of medical contraindications are also part of the evaluation